Our partner is a biopharmaceutical company founded on the development and commercialization of novel vaccine candidates, specifically and initially, vaccine development for norovirus. Their goal is to commercialize the first approved vaccine for norovirus infections which account for 212,000 deaths per year.
This CMC leader was a critical hire in the development and success of this new organization and led manufacturing, technical operations, supply chain, process development, analytical development, and sat on the executive leadership team while driving both tactical initiatives and strategic imperatives for the company.
days until hired candidate presented
candidates presented
days until search completed